Sandoz Repaglinide 0.5 mg

SANDOZ REPAGLINIDE 0.5 MG tablets are an oral medication used to manage blood sugar levels in adults with type 2 diabetes. This antidiabetic agent helps control glucose levels when diet and exercise alone are not sufficient.

Repaglinide is primarily used to improve glycemic control in adults with type 2 diabetes. It works by stimulating the pancreas to release more insulin in response to meals, helping to lower blood sugar levels. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise.

Common effects of repaglinide may include mild to moderate hypoglycemia, particularly if meals are skipped or delayed. Some users may experience gastrointestinal discomfort, such as nausea or diarrhea. It is important to monitor blood sugar levels regularly while using this medication.

Repaglinide should be used with caution in individuals with liver or kidney impairment. It is essential to follow the prescribed dosage and timing, as taking it too close to a meal or without food can increase the risk of low blood sugar. Always consult a healthcare provider before starting or adjusting any medication.

Repaglinide may interact with other medications, including certain antibiotics, antifungal agents, and drugs that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it can affect blood sugar levels and increase the risk of hypoglycemia.